Publicacions en col·laboració amb investigadors/es de GlaxoSmithKline (Spain) (2)

2022

  1. Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment

    Expert Opinion on Biological Therapy, Vol. 22, Núm. 7, pp. 821-829

2003

  1. A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

    Journal of Hepatology